Primary Site >> Colorectal Cancer
Gene >> SLC34A2
| 1. | |||||||||||
| Journal: | Cancer. 2013 May 1;119(9):1627-35. | ||||||||||
| Title: | Identification of ROS1 rearrangement in gastric adenocarcinoma. | ||||||||||
| Author: | Lee, Jeeyun|Lee, Seung Eun|Kang, So Young|Do, In-Gu|Lee, Sujin|Ha, Sang Yun|Cho, Jeonghee|Kang, Won Ki|Jang, Jiryeon|Ou, Sai-Hong Ignatius|Kim, Kyoung-Mee | ||||||||||
| PMID: | 23400546 | ||||||||||
| 2. | |||||||||||
| Journal: | Mol Cancer Res. 2014 Jan;12(1):111-8. | ||||||||||
| Title: | ROS1 and ALK fusions in colorectal cancer, with evidence of intratumoral heterogeneity for molecular drivers. | ||||||||||
| Author: | Aisner, Dara L|Nguyen, Teresa T|Paskulin, Diego D|Le, Anh T|Haney, Jerry|Schulte, Nathan|Chionh, Fiona|Hardingham, Jenny|Mariadason, John|Tebbutt, Niall|Doebele, Robert C|Weickhardt, Andrew J|Varella-Garcia, Marileila | ||||||||||
| PMID: | 24296758 | ||||||||||
| 3. | |||||||||||
| Journal: | Pharmacol Res. 2017 Jul;121:202-212. | ||||||||||
| Title: | ROS1 protein-tyrosine kinase inhibitors in the treatment of ROS1 fusion protein-driven non-small cell lung cancers. | ||||||||||
| Author: | Roskoski, Robert Jr | ||||||||||
| PMID: | 28465216 | ||||||||||
| 4. | |||||||||||
| Journal: | Biomed Pharmacother. 2018 Mar;99:645-654. | ||||||||||
| Title: | Solute carrier family 34 member 2 overexpression contributes to tumor growth and poor patient survival in colorectal cancer. | ||||||||||
| Author: | Liu, Liguo|Yang, Yi|Zhou, Xueming|Yan, Xuebing|Wu, Zhenqian | ||||||||||
| PMID: | 29653487 | ||||||||||
| 5. | |||||||||||
| Journal: | Biosci Rep. 2018 Jul 23. pii: BSR20180268. | ||||||||||
| Title: | The SLC34A2-ROS-HIF-1-induced upregulation of EZH2 expression promotes proliferation and chemo-resistance to apoptosis in colorectal cancer. | ||||||||||
| Author: | Li, Xu|Xing, Junjie|Wang, Hantao|Yu, Enda | ||||||||||
| PMID: | 30038060 | ||||||||||